Cincinnati

The trials here

What the 6 trials at this site are about, from their registry records.

Conditions

• Narcolepsy5 trials
• Bipolar disorder1 trial
• Schizophrenia1 trial

Phase

• Phase 34 trials
• Phase 21 trial
• Phase 2/31 trial

Status

• Recruiting4 trials
• Completed1 trial
• Enrolling by invitation1 trial

Lead sponsor

• Alkermes, Inc.6 trials

Running trials

• Recruiting

  A Study to Evaluate the Efficacy, Safety and Tolerability of ALKS 2680 in Adults With Narcolepsy Type 1 (Brilliance NT1 - 304)

  NCT07540897· Phase 3· Alkermes, Inc.· Source

  Contact: Director, Clinical Trial Manager

• Recruiting

  A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 2

  NCT07502443· Phase 3· Alkermes, Inc.· Source

  Contact: Director Clinical Trial Manager

• Recruiting

  A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1

  NCT07455383· Phase 3· Alkermes, Inc.· Source

  Contact: Director, Clinical Trial Manager

• Recruiting

  A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia

  NCT06767683· Phase 2/3· Alkermes, Inc.· Source

  Contact: Director, Global Clinical Services

• Enrolling by invitation

  Long-term Safety Extension Study of OLZ/SAM in Pediatric Subjects

  NCT04987229· Phase 3· Alkermes, Inc.· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Narcolepsy4 recruiting
• Bipolar disorder1 recruiting
• Schizophrenia1 recruiting

Closed trials

• Completed

  A Study to Evaluate the Safety and Effectiveness of ALKS 2680 in Subjects With Narcolepsy Type 1 (ALKS 2680-201)

  NCT06358950· Phase 2· Alkermes, Inc.· Source